Methotrexate (West-Ward Pharmaceuticals Corp)


Welcome to the PulseAid listing for the Methotrexate drug offered from West-Ward Pharmaceuticals Corp. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: West-Ward Pharmaceuticals Corp
NON-PROPRIETARY NAME: Methotrexate
SUBSTANCE NAME: METHOTREXATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
ROUTE: INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-09-06
END MARKETING DATE: 0000-00-00


Methotrexate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethotrexate from West-Ward Pharmaceuticals Corp
LABELER NAME: West-Ward Pharmaceuticals Corp
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2005-09-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0143-9830_2ffd9da2-5eb2-430a-93df-0d2423335edb
PRODUCT NDC: 0143-9830
APPLICATION NUMBER: ANDA040632

Other METHOTREXATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.Methotrexate
Antares Pharma, Inc.Otrexup
Cadila Healthcare LimitedMethotrexate
Mylan Institutional LLCMethotrexate
Pfizer Laboratories Div Pfizer Inc.Methotrexate
Physicians Total Care, Inc.METHOTREXATE
Silvergate Pharmaceuticals, Inc.Xatmep
West-Ward Pharmaceuticals CorpMethotrexate
Zydus Pharmaceuticals (USA) Inc.Methotrexate